Press Releases

A research team supported by the National Institutes of Health has identified a part of the brain that may be associated with breathing failure following a seizure in people with severe epilepsy that cannot be controlled with medication.

Researchers have identified uric acid as a potential therapy to enhance recovery from acute ischemic stroke using a new method for conducting preclinical animal research.

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or “biomarker” related to clinical signs of recovery from treatment-resistant depression.

Study examined athletes who played contact sports, showed CTE symptoms, and died before age 30.

The results of an early-stage clinical trial indicate that deep brain stimulation (DBS) applied to the cerebellum may help recovery of upper limb function following stroke.

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, released a new strategic plan to identify research opportunities that may help eliminate health disparities and inequities in neurological disorders.

NIH-supported trial first step in developing new approach to treat myasthenia gravis

NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment.

For the first time, researchers have recorded pain-related data from inside the brain of individuals with chronic pain disorders caused by stroke or amputation (phantom limb pain).

Among people who have had COVID-19, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of long COVID than those without the sleep disorder, according to a large study supported by the National Institutes of Health (NIH).